MedTrace Logo

Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy

NCT04380064 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-11-18

No results posted yet for this study

Summary

Subject/Participant Groups:

Study Group: Subjects undergo internal limiting membrane (ILM) peeling during vitrectomy for the indication of tractional retinal detachment Control Group: Subjects do not undergo ILM peeling during vitrectomy for the indication of tractional retinal detachment

Conditions

  • Diabetic Retinopathy Visually Threatening

Interventions

PROCEDURE

ILM Peeling

ILM peeling performed during primary PPV for PDR

PROCEDURE

No ILM Peeling

ILM peeling not performed during primary PPV for PDR

Sponsors & Collaborators

  • Rush Eye Associates

    lead OTHER

Principal Investigators

  • Sloan Rush, MD · panhandle eye group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2025-02-01
Completion
2025-02-01

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04380064 on ClinicalTrials.gov